Our ongoing investigation will reveal how UBXN2A, CHIP, and mot‐2 cross talk in CRC patient tissues, including adenoma, adenocarcinoma, and normal intestinal tissues. This evidence concerns the gene HSPA9 and colorectal carcinoma.